Vonoprazan Versus Lansoprazole for the Initial Treatment of Reflux Esophagitis: A Cost-Effectiveness Analysis in Japan

Internal Medicine- Japan

doi 10.2169/internalmedicine.2535-18

Full Text

Abstract

Available in

Categories

Internal Medicine

Date

September 1, 2019

Authors

Publisher

Japanese Society of Internal Medicine

Related search

Randomised Clinical Trial: Vonoprazan Versus Lansoprazole for the Initial Relief of Heartburn in Patients With Erosive Oesophagitis

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Cost Effectiveness Analysis of the Threshold for Initial Hypertension Treatment- A Markov Study Following the Jnc8 Guideline

Value in Health

Occupational Health

English

Cost-Effectiveness Analysis of Celecoxib in the Treatment of Patients With Chronic Pain in Japan

English

Cost-Effectiveness of Gemcitabine Plus Cisplatin Versus Gemcitabine Alone for Treatment of Advanced Biliary Tract Cancer in Japan

Value in Health

Occupational Health

English

Cost-Effectiveness Analysis of Endovascular Versus Neurosurgical Treatment for Ruptured Intracranial Aneurysms in the United States

Journal of Neurosurgery

English

Pcn188 - Assessing the Robustness of a Cost-Effectiveness Analysis of Lenvatinib Versus Sorafenib in Unresectable Hepatocellular Carcinoma in Japan

Value in Health

Occupational Health

English

The Cost Effectiveness Analysis of Indacaterol Versus Tiotropium in a Chinese Medical Cost Setting

Value in Health

Occupational Health

English

Pms38 - Cost Effectiveness Analysis of Secukinumab Versus Ustekinumab for the Treatment of Psoriatic Arthritis in the United States

Value in Health

Occupational Health

English

Cost-Effectiveness Analysis of Mass Screening for Cervical Cancer in Japan

Journal of Epidemiology

English